3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
86
Blood Specimen Collection
59
Interviews as Topic
28
Observation
15
Data Collection
15
Radiotherapy
13
Drug Therapy
12
Watchful Waiting
11
Magnetic Resonance Spectroscopy
11
Hematologic Tests
11
Exercise
11
Quality of Life
9
Biopsy
8
Specimen Handling
7
Therapeutics
6
Restraint, Physical
6
Magnetic Resonance Imaging
6
Focus Groups
6
pembrolizumab
5
Standard of Care
5
Rivaroxaban
5
Phlebotomy
5
Nivolumab
5
Lapatinib
5
Immune Checkpoint Inhibitors
5
Antineoplastic Agents
5
atezolizumab
4
apixaban
4
Trastuzumab
4
Patient Reported Outcome Measures
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasms
×
sodium-iodide symporter
×
Clear all
NCT02733601
2023-04-03
BreCaReAl
AstraZeneca
Completed
1,500 enrolled